Metformin versus Insulin for the Treatment of Gestational Diabetes
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Metformin is a logical treatment for women with gestational diabetes mellitus, but randomized trials to assess the efficacy and safety of its use for this condition are lacking. METHODS: We randomly assigned 751 women with gestational diabetes mellitus at 20 to 33 weeks of gestation to open treatment with metformin (with supplemental insulin if required) or insulin. The primary outcome was a composite of neonatal hypoglycemia, respiratory distress, need for phototherapy, birth trauma, 5-minute Apgar score less than 7, or prematurity. The trial was designed to rule out a 33% increase (from 30% to 40%) in this composite outcome in infants of women treated with metformin as compared with those treated with insulin. Secondary outcomes included neonatal anthropometric measurements, maternal glycemic control, maternal hypertensive complications, postpartum glucose tolerance, and acceptability of treatment. RESULTS: Of the 363 women assigned to metformin, 92.6% continued to receive metformin until delivery and 46.3% received supplemental insulin. The rate of the primary composite outcome was 32.0% in the group assigned to metformin and 32.2% in the insulin group (relative risk, 0.99 [corrected]; 95% confidence interval, 0.80 [corrected] to 1.23 [corrected]). More women in the metformin group than in the insulin group stated that they would choose to receive their assigned treatment again (76.6% vs. 27.2%, P<0.001). The rates of other secondary outcomes did not differ significantly between the groups. There were no serious adverse events associated with the use of metformin. CONCLUSIONS: In women with gestational diabetes mellitus, metformin (alone or with supplemental insulin) is not associated with increased perinatal complications as compared with insulin. The women preferred metformin to insulin treatment. (Australian New Zealand Clinical Trials Registry number, 12605000311651.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While individual RCTs support limited efficacy of metformin (73,74) and glyburide (75) in reducing glucose levels for the treatment of GDM, these agents are not recommended as the first-line treatment for GDM because they are known to cross the placenta and data on long-term safety for offspring is of some concern (35).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [73]
In the citing paper
“It was concluded that metformin alone, or with supplemental insulin, was not associated with increased perinatal complications.”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [112]
In the citing paper
“Blood glucose-lowering pharmacological therapy is effective at improving outcomes in women with gestational diabetes whose hyperglycemia does not respond sufficiently to lifestyle therapy (71, 82, 88–90).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [90]
In the citing paper
“Blood glucose-lowering pharmacological therapy is effective at improving outcomes in women with gestational diabetes whose hyperglycemia does not respond sufficiently to lifestyle therapy (71, 82, 88–90).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [89]
In the citing paper
“Glyburide is effective in controlling blood glucose in women with gestational diabetes”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [90]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Dabelea, D., Hanson, R. L., Lindsay, R. S., Pettitt, D. J., Imperatore, G., Gabir, M. M., Roumain, J., Bennett, P. H., & Knowler, W. C. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2208 · Cited by 1,277
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084
A comparison of glyburide and insulin in women with gestational diabetes mellitus
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431601 · Cited by 924
Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes
Ben‐Haroush, A., Yogev, Y., & Hod, M. (2004) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00985.x · Cited by 856
Gestational diabetes: The consequences of not treating
Langer, O., Yogev, Y., Most, O., & Xenakis, E. M. J. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.11.039 · Cited by 677
Silverman, B. L., Metzger, B. E., Cho, N. H., & Loeb, C. A. (1995) · Diabetes Care · doi:10.2337/diacare.18.5.611 · Cited by 643
Hoffman, L., Nolan, C., Wilson, J. D., Oats, J. J. N., & Simmons, D. (1998) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1998.tb140192.x · Cited by 570
An Increase in the Incidence of Gestational Diabetes Mellitus: Northern California, 1991–2000
Ferrara, A., Kahn, H. S., Quesenberry, C. P., Riley, C., & Hedderson, M. M. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000113623.18286.20 · Cited by 452
Glueck, C. J., Phillips, H., Cameron, D., Sieve-Smith, L., & Wang, P. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01666-6 · Cited by 430
Research works printed but not linked: 3
- Coetzee EJ, 1980, S Afr Med J, 58, 795
- Coetzee EJ, 1984, S Afr Med J, 65, 635
- Gutzin SJ, 2003, Can J Clin Pharmacol, 10, 179
Cited by
Items 901–1,000 of 1,001
Oral macht auch bei Gestationsdiabetes Metformin das Rennen
Stupin, J. H. (2017) · Info Diabetologie · doi:10.1007/s15034-017-1167-2 · Cited by 1
Screening, Diagnosis, and Management of Gestational Diabetes
Moore, L. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-65518-5_6 · Cited by 1
Medical Management of Gestational Diabetes
Anwar, A., Ahmad, K., Karagianni, E., & Lindow, S. W. (2018) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2018.84045 · Cited by 2
The Endocrine System and Pregnancy
Eckert‐Norton, M., & Hendricks, S. (2019) · Springer eBooks · doi:10.1007/978-3-319-99817-6_42 · Cited by 2
THE ASSOCIATED FACTORS AND PREGNANCY OUTCOMES OF WOMEN WITH DIABETES IN PREGNANCY
Kim, A. N. T. (2018) · Journal of Medicine and Pharmacy · doi:10.34071/jmp.2018.5.16 · Cited by 1
(2011) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/s1134-2072(11)70128-1 · Cited by 3
Metformin in Pregnancy with Diabetes—Opinions from Several Latest Guidelines
Feng, Y., & Yang, H.-X. (2020) · Maternal-Fetal Medicine · doi:10.1097/fm9.0000000000000036 · Cited by 2
Ornoy, A., & Weber-Schöndorfer, C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-408078-2.00016-0 · Cited by 1
Screening, Diagnosis, and Management of GDM: An Update
Bagias, C., Xiarchou, A., & Saravanan, P. (2021) · Journal of Diabetology · doi:10.4103/jod.jod_101_20 · Cited by 3
Pharmacotherapy of Gestational Diabetes Mellitus: Current Recommendations
Radenković, M., & Jakovljević, A. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.100266 · Cited by 2
“Metformin’s use and effectiveness in the management of insulin-dependent T2DM in pregnancy have been supported by early research [35].”
ResultRommy, Karinaningrum, A. D., Luthfiananda, B., Aniq, L., Evelina, L. S., & Fauzi, R. (2022) · Indonesian Journal of Pharmacology and Therapy · doi:10.22146/ijpther.3244 · Cited by 1
Catalano, P. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-32108-2.00041-x · Cited by 1
Majeed, T., Adnan, R., Mubshar, I., Mahmood, H., Saba, K., Imam, S. F., Zafar, M. A.-F., & Bukhari, M. H. (2015) · The Professional Medical Journal · doi:10.17957/tpmj/15.3019 · Cited by 2
Nelson-Piercy, C. (2010) · CRC Press eBooks · doi:10.3109/9781841847382-6 · Cited by 1
Fraser, R., & Farrell, T. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5908-0.00044-2 · Cited by 1
Wissler, R. N. (2009) · Elsevier eBooks · doi:10.1016/b978-0-323-05541-3.00042-9 · Cited by 2
Paul, P. G., Kingsbury, B., Yenuberi, H., Tirkey, R. S., Benjamin, S., Rathore, S., Manimegalai, B., Antonisamy, B., & Mathews, J. E. (2023) · Current Medical Issues · doi:10.4103/cmi.cmi_95_22 · Cited by 1
Drug interactions for women with diabetes and obesity during pregnancy
Newman, C., Dunne, F., & Egan, A. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89904-8.00012-3 · Cited by 1
Fay, E., Simmons, L. E., & BROWN, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-82823-9.00008-8 · Cited by 1
Inflammation in Pregnant Women with Obesity and Gestational Diabetes Mellitus
Kim, T. S. (2023) · Contemporary Endocrinology · doi:10.1007/978-3-031-39721-9_9 · Cited by 1
Oladimeji, O. I., Harding, J. E., Gamble, G. D., Crowther, C. A., & Lin, L. (2023) · Acta Paediatrica · doi:10.1111/apa.17026 · Cited by 1
“19,21 This may have con - tributed to our observation that neonates whose mothers required both insulin and metformin for glycaemic control, compared to those whose mothers required either insulin or metformin alone, were at an increased risk of hypoglycaemia.”
BackgroundResultPreconception Care for Individuals with Diabetes
Mukherjee, S. M., Dawson, A., & Carey, K. M. (2023) · EMJ Diabetes · doi:10.33590/emjdiabet/10305435 · Cited by 1
Antidiabetic Therapy during Pregnancy: The Prescription Pattern in Italy
Locatelli, A., Ornaghi, S., Terzaghi, A., Belleudi, V., Fortinguerra, F., Poggi, F. R., Perna, S., Trotta, F., & MoM-Net Group (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20237139 · Cited by 1
“Both insulin and its analogues and oral antidiabetic drugs, including metformin and glibencamide, can be safely prescribed during pregnancy [14,15].”
BackgroundFan, X., Wang, C., Chen, L., Zhao, X., Wu, Y., & Zeng, G. (2024) · American Journal of Translational Research · doi:10.62347/nigm4906 · Cited by 2
Asatiani, N., Kurashvili, R. B., & Shelestova, E. (2024) · Series of Clinical and Medical Case Reports and Reviews · doi:10.54178/2993-3579.v2i1a2026 · Cited by 2
Reischer, T., Prossinger, S., Catic, A., Healy, E. F., Göbl, C. S., & Yerlikaya‐Schatten, G. (2024) · Journal of Diabetes Research · doi:10.1155/2024/5561761 · Cited by 4
“However, regarding the work by Rowan et al., metformin (alone or with supplemental insulin) is not associated with increased perinatal complications as compared with insulin [23].”
BackgroundResultBroshtilova, V., & Gantcheva, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-65300-1_26 · Cited by 1
Obesity and Gestational Outcomes
Egan, A. M., & Dennedy, M. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800872-0.00012-3 · Cited by 1
Sibai, B. M., & Habli, M. A. (2010) · Springer eBooks · doi:10.1007/978-1-84882-120-0_12 · Cited by 2
Александрович, Л. К., Reshetko, O. V., & Lutsevich, T. S. (2014) · Педиатрическая фармакология · doi:10.15690/pf.v11i2.953 · Cited by 1
Oral Antidiabetic Agents in Gestational Diabetes Mellitus- Shifting of Paradigm?
Amin, M., Hossain, M., Miah, M., Yasmin, R., Chowdhury, M., & Hoque, M. (1970) · Journal of Dhaka Medical College · doi:10.3329/jdmc.v17i2.6596 · Cited by 1
Rôle de la metformine dans le SOPK
Duranteau, L., Lefevre, P., Jeandidier, N., Simon, T., & Christin‐Maître, S. (2010) · Annales d Endocrinologie · doi:10.1016/j.ando.2009.12.006 · Cited by 3
Fatness, faltering metabolism and fecundity: an expanding challenge in reproductive medicine
Nelson, S. M., & Sattar, N. A. (2009) · The British Journal of Diabetes · doi:10.1177/1474651408101370 · Cited by 1
Metformina y gliburida en el tratamiento de la diabetes gestacional
de Santander, M. I. X. N. D. M. U. I., Hernández, A. A., Castillo, D. R., & de Santander, U. I. (2015) · Revista Médicas UIS · doi:10.18273/revmed.v28n3-2015008 · Cited by 5
Gestational Diabetes Mellitus: Diagnosis, Maternal and Fetal Outcomes, and Management
Ferrara, A. M., & Kim, C. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-250-6_13 · Cited by 2
“In the MiG study, Rowan et al. ( 54 ) randomized 751 women with GDM at 20–33 weeks of gestation to open treatment with metformin (with supplemental insulin if required) or insulin.”
BackgroundMethodChandalia, H. B., & Thadani, P. (2016) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-016-0467-8 · Cited by 1
Practical Aspects of Insulin Therapy
Crasto, W., Jarvis, J., & Davies, M. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-10939-8_6 · Cited by 1
Ferrell, G. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.014 · Cited by 1
Substance Use in Women and Pregnancy
Roche, N., & Oparaji, D. C. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.050 · Cited by 1
Nausea and Vomiting of Pregnancy and Hyperemesis Gravidarum
Akinlaja, O. A., & Gist, W. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.035 · Cited by 2
Palomba, S., & Fauser, B. C. J. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-45534-1_22 · Cited by 1
Diabetes in Pregnancy: Worldwide Perspective
Lee, I., & Maple-Brown, L. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-90988-2_20 · Cited by 1
Jain, R. K., Olejas, S., Goo, L. S., Bhavatharinin, N., Dengra, A. S., Shoghli, R., Davey, S., & Jain, R. (2019) · International Journal of Diabetes and Endocrinology · doi:10.11648/j.ijde.20190403.12 · Cited by 1
“Titre of Glibenclamide in umbilical cord plasma is around 70% of maternal levels and is therefore linked with the higher level of neo-born hypoglycaemia and LGA (macrosomia) if we compare with Metformin or Insulin in review (28).”
BackgroundInfluentialJacob, K. J., C, M. G. N., Paduppingal, S., & Safina Farsana, A. V. (2017) · Obsgyne Review Journal of Obstetric and Gynecology · doi:10.17511/joog.2017.i01.01 · Cited by 1
“3% of the patients in the metformin group needed additional insulin to maintain glycemic target [3].”
BackgroundInfluentialPhysical exercise and metformin in the prevention of pre-eclampsia: systematic review
do Nascimento, I. B., Nunes, M. M., & Fleig, R. (2020) · Fisioterapia em Movimento · doi:10.1590/1980-5918.033.ao41 · Cited by 2
“5% in the metformin group versus 7% in pregnant women who administered insulin [12].”
BackgroundClomiphene-Metformin in Comparison with Letrozole-Metformin in Overweight Infertile Women with PCOS
EL-Gharib, M. N. (2020) · Obstetrics Gynecology and Reproductive Sciences · doi:10.31579/2578-8965/037 · Cited by 1
Prescribing for pregnancy: managing diabetes
Hurrell, A., White, S. L., & Webster, L. (2021) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2019.000005 · Cited by 2
Abbas, S. H., & Khdair, S. A. (2021) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2021.00917 · Cited by 2
Spezielle Arzneimitteltherapie in der Schwangerschaft
(2012) · Elsevier eBooks · doi:10.1016/b978-3-437-21203-1.10002-0 · Cited by 1
Maternale Erkrankungen in der Schwangerschaft
Fischer, T., Grab, D., Grubert, T. A., Hantschmann, P., Kainer, F., Kästner, R., Kentenich, C. R. M., Klockenbusch, W., Lammert, F., Louwen, F., et al. (2016) · Elsevier eBooks · doi:10.1016/b978-3-437-23752-2.00017-1 · Cited by 2
(2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.02.036 · Cited by 5
Nelson-Piercy, C. (2015) · CRC Press eBooks · doi:10.1201/b18316-7 · Cited by 1
Levy, C. J. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2059-4_40 · Cited by 1
Yamamoto, J. M., & Murphy, H. R. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.2508 · Cited by 1
Hugo Maldonado, E., Gloria López, S., Jorge Hasbún, H., Hugo Salinas, P., Parra-Cordero, M., & Enrique Valdés, R. (2015) · Revista Hospital Clínico Universidad de Chile · doi:10.5354/2735-7996.2015.71353 · Cited by 3
Martine‐Edith, G., Johnson, W., & Petherick, E. (2023) · Maternal and Child Health Journal · doi:10.1007/s10995-023-03851-w · Cited by 1
“…and neonatal complications (Barrett et al., 2013; Ijäs et al., 2011; Niromanesh et al., 2012; Rowan et al., 2008; Tertti et al., 2013) but in terms of neonatal anthropometry, the evidence to date is largely based on birth weight (Niromanesh et al., 2012; Rowan et al., 2008; Tertti et al., 2008).”
BackgroundResultCurrent treatment for gestational diabetes
Salat, D., & Aguilera, C. (2015) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2016.02.025 · Cited by 1
Diabetes in Special Populations
Codario, R. A. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-441-8_15 · Cited by 1
Diabetic Management in Labor, Delivery, and Postdelivery
Graham, U., & McCance, D. R. (2017) · Wiley eBooks · doi:10.1002/9781119043805.ch23 · Cited by 1
Oral Hypoglycemic Agents in Pregnancy
Feig, D. S. (2010) · Wiley eBooks · doi:10.1002/9781444315196.ch11 · Cited by 2
Bristow, S. M. (2010) · Tuwhera (Auckland University of Technology) · Cited by 3
Lima, M. M., Villalobos, M., Aguirre, M., Uzcátegui, L., Paoli, M., & de Endocrinología, G. D. T. U. (2012) · SaberULA (Universidad de Los Andes) · Cited by 6
New Prescription Drug Labeling Regulations and the Demise of “the Letter”
Witkop, C. T. (2009) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181b5bacc · Cited by 1
Diabetes Mellitus in Pregnancy
Greene, M. F., Solomon, C. G., Lee, S. L., & Peterfreund, R. A. (2010) · Wiley eBooks · doi:10.1002/9781444323016.ch11 · Cited by 1
Influences of excess adiposity on reproductive function
Mahmood, T. A. (2009) · The British Journal of Diabetes · doi:10.1177/1474651409350280 · Cited by 1
EFFECT OF CINNAMOMUM ZEYLANICUM AND SYZYGIUM CUMINI ON GESTATIONAL DIABETIC RATS
Rekha, N. (2010) · Cited by 1
Clinical management of diabetes in pregnancy
Wynne, K. (2015) · Wiley eBooks · doi:10.1002/9781119121725.ch20 · Cited by 1
Gestational diabetes mellitus: an audit at Tygerberg Academic Hospital
Nhlapo, S. (2015) · SUNScholar (Stellenbosch University) · Cited by 2
Functional analysis of hepatic FOXO3 signalling in glucose and lipid metabolism
Gul, S. (2014) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-3289 · Cited by 2
Cundy, T. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch61 · Cited by 1
Endocrine disease in pregnancy
Nelson, C., & Germain, S. (2011) · doi:10.1093/med/9780199235292.003.0936 · Cited by 1
Cardiac function in gestational diabetes mellitus: A longitudinal study from fetal life to infancyPreprint
Charakida, M., Nicolaides, K. H., Semmler, J., Aguilera, J., Zhang, H., & Anzoatgui, S. (2020) · doi:10.22541/au.159200526.62960408 · Cited by 1
Diabetes mellitus und Schwangerschaft
Schaefer-Graf, U. M., Kautzky‐Willer, A., & Groten, T. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-44369-9_26-2 · Cited by 2
Sara, J., & Alsayari, R. (2011) · InTech eBooks · doi:10.5772/23830
Rationale for Treatment of Hyperglycemia in Pregnancy
Fraser, R. B. (2010) · Wiley eBooks · doi:10.1002/9781444315196.ch7
Glycaemic Control and other Interventions in the Treatment of Gestational Diabetes
McCance, D. R. (2010) · Wiley eBooks · doi:10.1002/9780470682807.ch11
Evaluación de las distintas estrategias diagnósticas para diabetes gestacional
Rodríguez, I. (2012) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Long‐Term Implications for the Baby of the Hyperglycemic Mother
Pettitt, D. J. (2010) · Wiley eBooks · doi:10.1002/9781444315196.ch25
Diabetes mellitus in der Schwangerschaft
Vollmer, T. (2007) · Springer eBooks · doi:10.1007/978-3-540-30098-4_15
Emerging concepts in metformin therapy: Hyperglycaemia and beyond
Fiad, T. M., Hammadi, F. A., Nuaimi, A. A., & Dhuhouri, J. A. (2013) · Ibnosina Journal of Medicine and Biomedical Sciences · doi:10.4103/1947-489x.210550
Neue deutsche Leitlinie zum Gestationsdiabetes: Konsequenzen für die Praxis
Kleinwechter, H. J. (2013) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Knowledge-Based System Model to Support Diabetes Research and Clinical Process
Hernández-Medrano, A., Urriolagoitia-Calderón, G., Hernández‐Simón, L. M., & Hernández-Gómez, L. H. (2011) · Revista Colombiana de Biotecnología
El feto en la paciente de alto riesgo obstétrico
Ospina, A. C. (2012) · Vitae (Universidad de Antioquia)
Where do conventional OADs stand
Sahay, R. K., & Nagesh, V. (2012) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.104053
“Some of the most favorable evidence for metformin was provided by the metformin in GDM study,[13] which found no significant increase in a composite measure of neonatal complications among women with GDM who were randomly assigned to metformin as compared with those who were assigned to insulin.”
BackgroundInsulintherapie in der Schwangerschaft
Schäfer-Graf, U. M. (2014) · Der Diabetologe · doi:10.1007/s11428-013-1152-x
Maternale Erkrankungen in der Schwangerschaft
Beinder, E., Fischer, T., Grab, D., Grubert, T. A., Hantschmann, P., Kainer, F., Kästner, R., Kentenich, C. R. M., Klockenbusch, W., Kopp, R., et al. (2012) · Elsevier eBooks · doi:10.1016/b978-3-437-23751-5.10017-2
Obesity and Metabolic Disorders During Pregnancy and Pregnancy Outcome
Visser, G. H. A., & Yogev, Y. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416045-3.00021-2
Management of gestational diabetes in primary care
Morris, D. (2013) · Independent Nurse · doi:10.12968/indn.2013.3.6.98888
The NICE guidelines for diabetes in pregnancy: questions and practicalities?
Cummings, M. (2008) · Practical Diabetes · doi:10.1002/pdi.1240
Brick by brick: metformin for gestational diabetes mellitus?
Ardilouze, J., Mahdavian, M., & Baillargeon, J. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.9
Dilemma Schwangerschaftsdiabetes: Weltweite Unterschiede in Diagnostik und Therapie
Zeck, W., Schlembach, D., Panzitt, T., Lang, U. E., & McIntyre, D. H. (2009) · Gyn�kologisch-geburtshilfliche Rundschau · doi:10.1159/000301086
Dilemas médicos desde la preconcepción hasta el parto: hoja de ruta para el internista
Carson, M., & Ehrenthal, D. B. (2008) · Clínicas médicas de Norteamérica
Medical Therapy in Pregnant Women with Diabetes
Lee, S. H., Ahn, J., & Kim, J. (2011) · Journal of Korean Diabetes · doi:10.4093/jkd.2011.12.4.201
Metformina versus insulina para el tratamiento de diabetes gestacional
Paula Vargas, I., & Jorge Carvajal, C. (2008) · Revista chilena de obstetricia y ginecología · doi:10.4067/s0717-75262008000400012
Henslee, E., Hatton, A., Welt, S. I., Holmes, J., Penrose, L. L., Prien, S. D., & Farooqi, N. (2014) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2014.416144
Maternal disorders affecting labor and delivery
Merriam, A. A., & SCISCIONE, A. C. (2015) · Wiley eBooks · doi:10.1002/9781118327241.ch13
Pharmacological Treatment Options for Gestational Diabetes
Langer, O. (2010) · Springer eBooks · doi:10.1007/978-1-84882-120-0_19
Managing gestational diabetes: timing, selection and use of pharmacotherapy
Thung, S., & Landon, M. B. (2013) · Diabetes Management · doi:10.2217/dmt.13.48
Gezielte Diagnostik ist das A und O
Stupin, J. H. (2015) · Info Diabetologie · doi:10.1007/s15034-015-0495-3
“36 IN|Fo|DIABETOLOGIE 2015; 9 (2) diskutiert [26, 27].”
La detección y manejo de la diabetes gestacional. Controversias, críticas y comentario
Zárate, A., Hernández-Valencia, M., & Saucedo, R. (2008) · Acta Médica Grupo Ángeles · Cited by 1
Metadata
- Authors
- Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P.
- Affiliations
- Auckland City Hospital (NZ)
- Women's and Children's Hospital (AU)
- Auckland University of Technology (NZ)
- University of Auckland (NZ)
- Christchurch Hospital (NZ)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-05-08
- Volume
- 358
- Issue
- 19
- Pages
- 2003-2015
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2003621575
- Cited by
- 1,291
- References
- 33
- Citations by year
- 2026: 49 · 2025: 60 · 2024: 52 · 2023: 65 · 2022: 63 · 2021: 90 · 2020: 67 · 2019: 66 · 2018: 105 · 2017: 125 · 2016: 68 · 2015: 82 · 2014: 69 · 2013: 62 · 2012: 56
- FWCI
- 78.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- metformin, insulin, gestational diabetes mellitus, neonatal hypoglycemia, perinatal complications, maternal glycemic control, postpartum glucose tolerance, treatment acceptability, treatment preferences, neonatal respiratory distress, phototherapy
- MeSH terms
- Adult, Drug Therapy, Combination, Female, Gestational Age, Humans, Hypoglycemia, Hypoglycemic Agents, Infant, Newborn, Insulin, Jaundice, Neonatal, Metformin, Pregnancy, Pregnancy Complications, Cardiovascular, Pregnancy Outcome, Diabetes, Gestational, Patient Satisfaction, Premature Birth
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.